Clinical Trials Logo

Infantile Haemangiomas clinical trials

View clinical trials related to Infantile Haemangiomas.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04651049 Completed - Clinical trials for Infantile Haemangiomas

Systemic Propranolol for the Treatment of Paediatric Patients With Infantile Hemangiomas

Start date: July 15, 2010
Phase:
Study type: Observational

This is retrospective study. The patients treated with oral propranolol at a dose of 2.0 mg/kg per day. Growth parameters (height and weight) were measured at the beginning, the end of treatment and 2 years after treatment. The weight-for-age Z-score (WAZ), height-for-age Z-score (HAZ) and weight-for-height Z-score (WHZ) calculated by the WHO Anthro software were used to assess physical development, and the WHO Child Growth Standards were used as the standards.